MetLife Investment Management’s Arcus Biosciences RCUS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$338K Buy
41,462
+8,451
+26% +$68.8K ﹤0.01% 1883
2025
Q1
$259K Sell
33,011
-514
-2% -$4.04K ﹤0.01% 2060
2024
Q4
$499K Buy
33,525
+2,521
+8% +$37.5K ﹤0.01% 1797
2024
Q3
$474K Hold
31,004
﹤0.01% 1815
2024
Q2
$472K Buy
31,004
+2,870
+10% +$43.7K ﹤0.01% 1747
2024
Q1
$531K Hold
28,134
﹤0.01% 1640
2023
Q4
$537K Hold
28,134
﹤0.01% 1644
2023
Q3
$505K Hold
28,134
﹤0.01% 1629
2023
Q2
$571K Buy
28,134
+1,203
+4% +$24.4K ﹤0.01% 1610
2023
Q1
$491K Hold
26,931
﹤0.01% 1654
2022
Q4
$557K Buy
26,931
+480
+2% +$9.93K ﹤0.01% 1573
2022
Q3
$692K Hold
26,451
0.01% 1404
2022
Q2
$670K Buy
26,451
+1,412
+6% +$35.8K 0.01% 1461
2022
Q1
$790K Buy
25,039
+9,127
+57% +$288K 0.01% 1475
2021
Q4
$644K Hold
15,912
0.01% 1367
2021
Q3
$555K Sell
15,912
-2,486
-14% -$86.7K 0.01% 1463
2021
Q2
$505K Hold
18,398
﹤0.01% 1561
2021
Q1
$517K Hold
18,398
﹤0.01% 1504
2020
Q4
$478K Hold
18,398
﹤0.01% 1512
2020
Q3
$315K Buy
18,398
+2,753
+18% +$47.2K ﹤0.01% 1603
2020
Q2
$387K Hold
15,645
﹤0.01% 1521
2020
Q1
$217K Hold
15,645
﹤0.01% 1654
2019
Q4
$158K Hold
15,645
﹤0.01% 2109
2019
Q3
$142K Hold
15,645
﹤0.01% 2136
2019
Q2
$124K Hold
15,645
﹤0.01% 2287
2019
Q1
$195K Hold
15,645
﹤0.01% 1996
2018
Q4
$168K Buy
+15,645
New +$168K ﹤0.01% 1997